Development of Central Nervous System Metastases in Patients with Advanced Non-Small Cell Lung Cancer and Somatic EGFR Mutations Treated with Gefitinib or Erlotinib

Lignende værker

• The Impact of Initial Gefitinib or Erlotinib versus Chemotherapy on Central Nervous System Progression in Advanced Non–Small Cell Lung Cancer with EGFR Mutations
  af: Heon, Stephanie, et al.
  Udgivet: (2012)
• Effects of erlotinib in EGFR mutated non-small cell lung cancers with resistance to gefitinib
  af: Costa, Daniel B., et al.
  Udgivet: (2008)
• Volumetric tumor response and progression in EGFR-mutant NSCLC patients treated with erlotinib or gefitinib
  af: Nishino, Mizuki, et al.
  Udgivet: (2016)
• Noninvasive Detection of EGFR T790M in Gefitinib or Erlotinib Resistant Non-Small Cell Lung Cancer
  af: Kuang, Yanan, et al.
  Udgivet: (2009)
• Temozolomide and/or Erlotinib in the Treatment of Lung Cancer Patients With Progressive Central Nervous System Metastases
  af: Lukas, Rimas V, et al.
  Udgivet: (2012)